| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Hematologic Diseases Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333
The protein C/protein S anticoagulant pathway has been proposed to be a common link between coagulation and inflammation. Studies have suggested that a component of the anticoagulant pathway, activated protein C (APC), may play a role in the inflammatory response by modulating the effects of cytokines such as TNF and by blocking neutrophil activation. Cytokines are known to be intimately involved in the inflammatory response and to function in part to restore hemostatic balance. To begin to delineate what role APC may have in the inflammatory response, we have investigated the effect of APC on the production of the proinflammatory cytokines IL-6 and IL-8 in primary HUVEC, human microvascular endothelial cells, and human coronary artery endothelial cells. Our results have demonstrated that physiologic concentrations of APC significantly up-regulated the production of both IL-6 and IL-8. This increase, which was seen at both the RNA and protein level, was not due to either thrombin or LPS contamination of the APC preparation. Additional studies also showed that the APC-mediated up-regulation of IL-6 and IL-8 was IL-1 independent. Although neither purified protein C nor protein S alone had an effect on cytokine production, protein S, the cofactor for APC, significantly enhanced the ability of APC to up-regulate IL-6/IL-8 production. These results provide further evidence for a role for APC in the inflammatory response.
This article has been cited by other articles:
|
|
 |
|
  S. T.B.G. Loubele, C. A. Spek, P. Leenders, R. van Oerle, H. L. Aberson, K. Hamulyak, G. Ferrell, C. T. Esmon, H. M.H. Spronk, and H. ten Cate Activated Protein C Protects Against Myocardial Ischemia/ Reperfusion Injury via Inhibition of Apoptosis and Inflammation Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1087 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells J. Biol. Chem., July 21, 2006; 281(29): 20077 - 20084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyamoto, M. Tomaki, J. Lotvall, and A. Linden {beta}-Adrenoceptor stimulation and neutrophil accumulation in mouse airways Eur. Respir. J., August 1, 2004; 24(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Rijneveld, S. Weijer, S. Florquin, C. T. Esmon, J. C. M. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide Blood, March 1, 2004; 103(5): 1702 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Weiler, V. Lindner, B. Kerlin, B. H. Isermann, S. B. Hendrickson, B. C. Cooley, D. A. Meh, M. W. Mosesson, N. W. Shworak, M. J. Post, et al. Characterization of a Mouse Model for Thrombomodulin Deficiency Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1531 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Sundstrom, L. K. McMullan, C. F. Spiropoulou, W. C. Hooper, A. A. Ansari, C. J. Peters, and P. E. Rollin Hantavirus Infection Induces the Expression of RANTES and IP-10 without Causing Increased Permeability in Human Lung Microvascular Endothelial Cells J. Virol., July 1, 2001; 75(13): 6070 - 6085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Y. Chan, J. G. Ganopolsky, I. Cornelissen, M. A. Suckow, M. J. Sandoval-Cooper, E. C. Brown, F. Noria, D. Gailani, E. D. Rosen, V. A. Ploplis, et al. The Characterization of Mice with a Targeted Combined Deficiency of Protein C and Factor XI Am. J. Pathol., February 1, 2001; 158(2): 469 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ricotta, G. Alessandri, C. Pollara, S. Fiorentini, F. Favilli, M. Tosetti, A. Mantovani, M. Grassi, E. Garrafa, L. Dei Cas, et al. Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus Cardiovasc Res, February 1, 2001; 49(2): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J T Merrill and R G Lahita Sex hormone binding globulins and atherosclerotic risk in systemic lupus Lupus, March 1, 2000; 9(3): 217 - 222. [Abstract] [PDF]
|
|
|
|
|
|
E. de Jonge, P. E. P. Dekkers, A. A. Creasey, C. E. Hack, S. K. Paulson, A. Karim, J. Kesecioglu, M. Levi, S. J. H. van Deventer, and T. van der Poll Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia Blood, February 15, 2000; 95(4): 1124 - 1129. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
